Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
UAB 1033/TBCRC 018: A Phase II Study of the PARP Inhibitor, INIPARIB (BSI-201) in Combination with Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis
Grant
Overview
Affiliation
Overview
Awarded By
Johns Hopkins University
Total Award Amount
27200.00
Direct Costs
24727.00
Sponsor Award Id
Affiliation
Contributor
Lisle Nabell M.D.
Investigator